Actualités 2108.html

Images about 2108.html

Palisade Bio begins dosing subjects in last cohort of ulcerative colitis drug trial

Mon, 17 Mar 2025 04:49:57 GMT

The trial’s primary objective is to assess PALI-2108’s tolerability, pharmacokinetics and safety in healthy volunteers.